| Editor's Choice: Heart Failure | Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions. Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions. | | |
| The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement. The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement. | | |
| New research out of Duke University provides a fresh perspective on the connection between prior hospitalizations for heart failure and all-cause mortality. New research out of Duke University provides a fresh perspective on the connection between prior hospitalizations for heart failure and all-cause mortality. | | |
| The study, published in Hypertension, included data from more than 8,000 U.S. veterans. The study, published in Hypertension, included data from more than 8,000 U.S. veterans. | | |
| The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction. The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction. | | |
| The study’s authors tracked data from more than 2,800 patients with HFrEF, sharing their findings in JAMA Cardiology. The study’s authors tracked data from more than 2,800 patients with HFrEF, sharing their findings in JAMA Cardiology. | | |
| The guidance, an update to a similar document from 2005, was published in Circulation: Cardiovascular Quality and Outcomes. The guidance, an update to a similar document from 2005, was published in Circulation: Cardiovascular Quality and Outcomes. | | |
| | The company also hopes to launch an early feasibility study in the United States in the near future. The company also hopes to launch an early feasibility study in the United States in the near future. | | |
| |
|
| ![]() | |
|
![Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2018-08/olderpatient-doctor.jpg?itok=o-2DfhVK)
